Senior Manager, Financial Reporting
Poseida Therapeutics is seeking an exceptional Senior Manager, Financial Reporting who will be responsible for preparing and reviewing all SEC filings to provide timely and accurate financial reporting in compliance with SEC regulations. This role reports to the Vice President, Finance and will lead internal and external financial reporting function and ensure that accounting is compliant with all company quality standards and regulations.

Primary Responsibilities:

  • Prepare financial statements and related footnotes, as required, including Form 10K and 10Q to be filed with the SEC
  • Responsible for internal monthly financial reporting, including preparation of consolidated financial statements for leadership team and BOD
  • Research and analyze technical accounting and financial reporting issues, assess impact to organization, formalize positions and recommendations, and write white-papers to support conclusion
  • Stay current on all new accounting literature, SEC rules and regulations, coordinating implementation as appropriate
  • Interface with external auditors, including preparation of audit schedules and respond to auditor inquiries, ensuring any audit issues are resolved in a timely manner
  • Prepare, publish and maintain a formal calendar/time-line of events associated with all filings including reviews by internal personnel, disclosure committee, and the audit committee of the board of directors
  • Assess internal control environment and initiate implementation of new structure to ensure compliance with Sarbanes-Oxley
  • Support accounting for all equity activity, including stock-based compensation expense and EPS
  • Coordinate financial reporting related to tax compliance and tax provision support
  • Engage and coordinate the work of various service providers as needed
  • Manage and complete special projects as required


  • Bachelor’s degree in Finance/Accounting
  • Progressive experience in publicly traded companies
  • CPA and Public Accounting experience preferred
  • Experience with SEC reporting tools/platforms such Active Disclosure or Workiva
  • Strong technical understanding of accounting and auditing regulations
  • Ability to work well under pressure and tight deadlines
  • Excellent analytical skills
  • Strong attention to detail
  • Self-motivated, proactive and able to quickly adapt to change

About Poseida

Poseida Therapeutics is a clinical-stage biotechnology company leveraging proprietary next-generation non-viral, gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need. The company is developing a wholly-owned pipeline of autologous and allogeneic CAR-T product candidates, initially focused on the treatment of hematological malignancies and solid tumors. Poseida’s product candidates are designed to address the limitations of other CAR-T therapies, including duration of response, the ability to treat solid tumors and safety concerns. P-BCMA-101 is Poseida’s lead CAR-T therapy currently in Phase 1 clinical development for the treatment of relapsed/refractory multiple myeloma. For more information, visit



Interested in this opportunity?

Interested candidates, please send resumes to:


ABFO, The Association of Bioscience Financial Officers

To view this html email as a webpage in your browser, please use this link.

Please visit for additional postings.


ABFO posts job openings with member companies on this site as a service to our members and makes no
representations or assurances regarding these positions. Our responsibility for any errors made by us in listing a position is limited to re-posting a correction on this site.
Please contact the individual company as set forth in a particular job description if you have any questions.

You are receiving this notice because you have indicated interest in ABFO, are an ABFO Member Representative, or have come to one of our meetings.
If you have questions or comments or wish to be removed from our distribution list,
please contact the ABFO Membership Coordinator, Genie Hawkins at